Home › Companies › CRINETICS PHARMACEUTICALS INC. › 2024-2025
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and CRINETICS PHARMACEUTICALS INC.’s Form 8-K, filed June 12, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 11, 2025: 5 items on CRINETICS PHARMACEUTICALS INC.’s Form 8-K, filed June 12, 2025: 2 approved · 3 passed (calculated).
Significant dissent: 1 director (20.7% against).
Notable dissent: 2 directors (19.3%, 18.4% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore CRINETICS PHARMACEUTICALS INC. in the interactive database Compare manager voting policies
These tallies are CRINETICS PHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 12, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: R. Scott Struthers, Ph.D. | 69,586,919 | -- | -- | 15,729,147 | 3,615,529 | 82% | Passed (calculated) | — |
| Elect Director: Matthew K. Fust | 67,615,092 | -- | -- | 17,700,974 | 3,615,529 | 79% | Passed (calculated) | — |
| Elect Director: Rogério Vivaldi Coelho, M.D. | 68,864,528 | -- | -- | 16,451,538 | 3,615,529 | 81% | Passed (calculated) | — |
| 2. Ratification of Selection of Independent Registered Accounting Firm | 88,742,805 | 129,064 | 59,727 | -- | 0 | 99.9% | Approved | — |
| 3. Approval, on an advisory basis, of the compensation of the Company's named executive officers | 82,658,715 | 2,636,436 | 20,915 | -- | 3,615,529 | 97% | Approved | — |
Source: CRINETICS PHARMACEUTICALS INC., Form 8-K, filed with the SEC on June 12, 2025 — read the filing on EDGAR.
See voting trends for Health Care companies, 2024-2025: shareholder support by sector and by company size.
245 asset managers disclosed a vote on at least one CRINETICS PHARMACEUTICALS INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 4 wordings of this item as funds reported it.
79% Majority: yes · of votes cast
Description as filed by funds: To elect three directors to serve as Class I directors for a three-year term to expire at the 2028 annual meeting of stockholders: Matthew K. Fust
CRINETICS PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Matthew K. Fust”): 67,615,092 for, 17,700,974 withheld, per its Form 8-K filed June 12, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 79% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 74 asset managers below reported 39,770,402 for, 5,804,857 withheld, 0 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 14,100,477 | 0 | 0 | 0 | For |
| Vanguard | 12,386,585 | 0 | 0 | 0 | For |
| T. Rowe Price | 4,083,567 | 0 | 0 | 0 | For |
| BlackRock | 2,807,048 | 0 | 0 | 0 | For |
| Prudential/PGIM | 991,701 | 0 | 0 | 152,686 | Mixed |
| State Street | 1,138,130 | 0 | 0 | 1,441 | For |
| JANUS INVESTMENT FUND | 0 | 0 | 0 | 1,088,848 | Withhold |
| Bridge Builder Trust | 17,922 | 0 | 0 | 997,109 | Withhold |
| DRIEHAUS MUTUAL FUNDS | 0 | 0 | 0 | 901,769 | Withhold |
| Charles Schwab | 763,288 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 607,646 | Withhold |
| Manager Directed Portfolios | 466,010 | 0 | 0 | 0 | For |
| TIAA | 405,093 | 0 | 0 | 0 | For |
| Hartford | 397,744 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 2,515 | 0 | 0 | 338,801 | Withhold |
| Aberdeen | 0 | 0 | 0 | 280,347 | Withhold |
| Victory Capital | 829 | 0 | 0 | 273,922 | Withhold |
| Equitable | 160,600 | 0 | 0 | 99,820 | Mixed |
| John Hancock | 198,005 | 0 | 0 | 50,369 | Mixed |
| Voya | 245,997 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 228,926 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 188,805 | 0 | 0 | 0 | For |
| Jackson National | 0 | 0 | 0 | 173,541 | Withhold |
| New York Life | 91,278 | 0 | 0 | 47,847 | Mixed |
| Northwestern Mutual | 129,886 | 0 | 0 | 0 | For |
Showing the 25 largest of 74 asset managers. All 74 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
82% Majority: yes · of votes cast
Description as filed by funds: To elect three directors to serve as Class I directors for a three-year term to expire at the 2028 annual meeting of stockholders: R. Scott Struthers, Ph.D.
CRINETICS PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: R. Scott Struthers, Ph.D.”): 69,586,919 for, 15,729,147 withheld, per its Form 8-K filed June 12, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 82% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 74 asset managers below reported 40,447,665 for, 5,127,594 withheld, 0 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 14,100,477 | 0 | 0 | 0 | For |
| Vanguard | 12,386,585 | 0 | 0 | 0 | For |
| T. Rowe Price | 4,083,567 | 0 | 0 | 0 | For |
| BlackRock | 2,807,048 | 0 | 0 | 0 | For |
| Prudential/PGIM | 991,701 | 0 | 0 | 152,686 | Mixed |
| State Street | 1,138,130 | 0 | 0 | 1,441 | For |
| JANUS INVESTMENT FUND | 755,632 | 0 | 0 | 333,216 | Mixed |
| Bridge Builder Trust | 17,922 | 0 | 0 | 997,109 | Withhold |
| DRIEHAUS MUTUAL FUNDS | 0 | 0 | 0 | 901,769 | Withhold |
| Charles Schwab | 763,288 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 607,646 | Withhold |
| Manager Directed Portfolios | 466,010 | 0 | 0 | 0 | For |
| TIAA | 405,093 | 0 | 0 | 0 | For |
| Hartford | 397,744 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 2,515 | 0 | 0 | 338,801 | Withhold |
| Aberdeen | 0 | 0 | 0 | 280,347 | Withhold |
| Victory Capital | 829 | 0 | 0 | 273,922 | Withhold |
| Equitable | 260,420 | 0 | 0 | 0 | For |
| John Hancock | 198,005 | 0 | 0 | 50,369 | Mixed |
| Voya | 0 | 0 | 0 | 245,997 | Withhold |
| FRANKLIN STRATEGIC SERIES | 228,926 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 188,805 | 0 | 0 | 0 | For |
| Jackson National | 0 | 0 | 0 | 173,541 | Withhold |
| New York Life | 91,278 | 0 | 0 | 47,847 | Mixed |
| Northwestern Mutual | 129,886 | 0 | 0 | 0 | For |
Showing the 25 largest of 74 asset managers. All 74 are in the interactive database (link above).
Combines 9 wordings of this item as funds reported it.
81% Majority: yes · of votes cast
Description as filed by funds: To elect three directors to serve as Class I directors for a three-year term to expire at the 2028 annual meeting of stockholders: Rogerio Vivaldi Coelho, M.D.
CRINETICS PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Rogério Vivaldi Coelho, M.D.”): 68,864,528 for, 16,451,538 withheld, per its Form 8-K filed June 12, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 81% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 74 asset managers below reported 39,828,513 for, 5,746,746 withheld, 0 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 14,100,477 | 0 | 0 | 0 | For |
| Vanguard | 12,386,585 | 0 | 0 | 0 | For |
| T. Rowe Price | 4,083,567 | 0 | 0 | 0 | For |
| BlackRock | 2,807,048 | 0 | 0 | 0 | For |
| Prudential/PGIM | 991,701 | 0 | 0 | 152,686 | Mixed |
| State Street | 1,138,130 | 0 | 0 | 1,441 | For |
| JANUS INVESTMENT FUND | 0 | 0 | 0 | 1,088,848 | Withhold |
| Bridge Builder Trust | 17,922 | 0 | 0 | 997,109 | Withhold |
| DRIEHAUS MUTUAL FUNDS | 0 | 0 | 0 | 901,769 | Withhold |
| Charles Schwab | 763,288 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 607,646 | Withhold |
| Manager Directed Portfolios | 466,010 | 0 | 0 | 0 | For |
| TIAA | 405,093 | 0 | 0 | 0 | For |
| Hartford | 397,744 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 2,515 | 0 | 0 | 338,801 | Withhold |
| Aberdeen | 0 | 0 | 0 | 280,347 | Withhold |
| Victory Capital | 829 | 0 | 0 | 273,922 | Withhold |
| Equitable | 160,600 | 0 | 0 | 99,820 | Mixed |
| John Hancock | 198,005 | 0 | 0 | 50,369 | Mixed |
| Voya | 245,997 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 228,926 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 188,805 | 0 | 0 | 0 | For |
| Jackson National | 0 | 0 | 0 | 173,541 | Withhold |
| New York Life | 91,278 | 0 | 0 | 47,847 | Mixed |
| Northwestern Mutual | 129,886 | 0 | 0 | 0 | For |
Showing the 25 largest of 74 asset managers. All 74 are in the interactive database (link above).
Combines 13 wordings of this item as funds reported it.
97% Approved · of votes cast
Prior year: 97.3% for (June 7, 2024 meeting) ▼ 0.4 pts
Description as filed by funds: To consider and vote upon, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission;
CRINETICS PHARMACEUTICALS INC.’s own tally for this item (“3. Approval, on an advisory basis, of the compensation of the Company's named executive officers”): 82,658,715 for, 2,636,436 against — passed, per its Form 8-K filed June 12, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal Three - Approval, on an advisory basis, of the compensation of the Company's named executive officers The Company's stockholders approved, on an advisory basis, the compensation of the Company's named executive officers.”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 14,100,477 | 0 | 0 | 0 | For |
| Vanguard | 12,385,807 | 778 | 0 | 0 | For |
| T. Rowe Price | 4,083,567 | 0 | 0 | 0 | For |
| BlackRock | 2,807,048 | 0 | 0 | 0 | For |
| Prudential/PGIM | 1,144,387 | 0 | 0 | 0 | For |
| State Street | 1,139,514 | 57 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,088,848 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 1,009,079 | 5,952 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 901,769 | 0 | 0 | 0 | For |
| Charles Schwab | 763,288 | 0 | 0 | 0 | For |
| American Century | 0 | 607,646 | 0 | 0 | Against |
| Manager Directed Portfolios | 466,010 | 0 | 0 | 0 | For |
| TIAA | 405,093 | 0 | 0 | 0 | For |
| Hartford | 397,744 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 341,316 | 0 | 0 | 0 | For |
| Aberdeen | 280,347 | 0 | 0 | 0 | For |
| Victory Capital | 274,751 | 0 | 0 | 0 | For |
| Equitable | 260,420 | 0 | 0 | 0 | For |
| John Hancock | 248,374 | 0 | 0 | 0 | For |
| Voya | 245,997 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 228,926 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 188,805 | 0 | 0 | 0 | For |
| Jackson National | 173,541 | 0 | 0 | 0 | For |
| New York Life | 139,125 | 0 | 0 | 0 | For |
| Northwestern Mutual | 129,886 | 0 | 0 | 0 | For |
Fund voting reports, all 74 managers: 44,924,666 for, 642,835 against, 7,758 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 13,927,584 | 0 | 0 | 0 | For |
| Wellington | 5,654,495 | 0 | 0 | 0 | For |
| T. Rowe Price | 5,551,210 | 0 | 0 | 0 | For |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4,495,194 | 0 | 0 | 0 | For |
| FARALLON CAPITAL MANAGEMENT LLC | 2,849,299 | 0 | 0 | 0 | For |
| State Street | 2,567,233 | 25,654 | 0 | 0 | For |
| BlackRock | 2,255,150 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 2,206,721 | 0 | 0 | 0 | For |
| Janus Henderson | 1,907,371 | 4,417 | 0 | 0 | For |
| JENNISON ASSOCIATES LLC | 1,854,208 | 2,682 | 0 | 0 | For |
| Siren, L.L.C. | 1,688,611 | 0 | 0 | 0 | For |
| Paradigm Biocapital Advisors LP | 1,494,974 | 0 | 0 | 0 | For |
| Novo Holdings A/S | 1,275,000 | 0 | 0 | 0 | For |
| ORBIMED ADVISORS LLC | 1,148,500 | 0 | 0 | 0 | For |
| Vestal Point Capital, LP | 951,565 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 927,328 | 0 | 0 | 0 | For |
| Hood River Capital Management LLC | 837,932 | 0 | 0 | 0 | For |
| First Light Asset Management, LLC | 821,314 | 0 | 0 | 0 | For |
| GW&K Investment Management, LLC | 285,624 | 0 | 0 | 0 | For |
| Charles Schwab | 763,477 | 0 | 0 | 0 | For |
| Northern Trust | 654,343 | 4,173 | 0 | 0 | For |
| FRANKLIN ADVISERS INC | 656,335 | 0 | 0 | 0 | For |
| American Century | 0 | 636,241 | 0 | 0 | Against |
| Fisher Asset Management, LLC | 609,774 | 0 | 0 | 0 | For |
| BNP Paribas Asset Management Holding S.A. | 0 | 580,362 | 0 | 0 | Against |
Institutional-manager reports, all 195 managers: 62,000,524 for, 1,925,486 against, 2,324 abstained, 13,667 not voted, 505,019 mixed. Showing the 25 largest; every one is in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99.9% Approved · of votes cast
Prior year: 99.8% for (June 7, 2024 meeting) unchanged
Description as filed by funds: To consider and vote upon the ratification of the selection of BDO USA, P.C. as our independent registered public accounting firm for the fiscal year ending December 31, 2025;
CRINETICS PHARMACEUTICALS INC.’s own tally for this item (“2. Ratification of Selection of Independent Registered Accounting Firm”): 88,742,805 for, 129,064 against — passed, per its Form 8-K filed June 12, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal Two - Ratification of Selection of Independent Registered Accounting Firm The Company's stockholders ratified the selection of BDO USA, P.C. as the Company's independent registered accounting firm for the fiscal year ending December 31, 2025.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 74 asset managers below reported 45,566,865 for, 636 against, 7,758 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 14,100,477 | 0 | 0 | 0 | For |
| Vanguard | 12,386,585 | 0 | 0 | 0 | For |
| T. Rowe Price | 4,083,567 | 0 | 0 | 0 | For |
| BlackRock | 2,807,048 | 0 | 0 | 0 | For |
| Prudential/PGIM | 1,144,387 | 0 | 0 | 0 | For |
| State Street | 1,139,514 | 57 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,088,848 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 1,015,031 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 901,769 | 0 | 0 | 0 | For |
| Charles Schwab | 763,288 | 0 | 0 | 0 | For |
| American Century | 607,646 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 466,010 | 0 | 0 | 0 | For |
| TIAA | 405,093 | 0 | 0 | 0 | For |
| Hartford | 397,744 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 341,316 | 0 | 0 | 0 | For |
| Aberdeen | 280,347 | 0 | 0 | 0 | For |
| Victory Capital | 274,751 | 0 | 0 | 0 | For |
| Equitable | 260,420 | 0 | 0 | 0 | For |
| John Hancock | 248,374 | 0 | 0 | 0 | For |
| Voya | 245,997 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 228,926 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 188,805 | 0 | 0 | 0 | For |
| Jackson National | 173,541 | 0 | 0 | 0 | For |
| New York Life | 139,125 | 0 | 0 | 0 | For |
| Northwestern Mutual | 129,886 | 0 | 0 | 0 | For |
Showing the 25 largest of 74 asset managers. All 74 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 93,525,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 15.08% |
| 2 | Vanguard | 13.24% |
| 3 | T. Rowe Price | 4.37% |
| 4 | BlackRock | 3.00% |
| 5 | Prudential/PGIM | 1.22% |
| 6 | State Street | 1.22% |
| 7 | JANUS INVESTMENT FUND | 1.16% |
| 8 | Bridge Builder Trust | 1.09% |
| 9 | DRIEHAUS MUTUAL FUNDS | 0.96% |
| 10 | Charles Schwab | 0.82% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 14.89% |
| 2 | Wellington | 6.05% |
| 3 | T. Rowe Price | 5.94% |
| 4 | DRIEHAUS CAPITAL MANAGEMENT LLC | 4.81% |
| 5 | FARALLON CAPITAL MANAGEMENT LLC | 3.05% |
| 6 | State Street | 2.77% |
| 7 | BlackRock | 2.41% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 2.36% |
| 9 | Janus Henderson | 2.04% |
| 10 | JENNISON ASSOCIATES LLC | 1.99% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| FMR (Fidelity) | 14,031,269 | 15.00% | Form 13F, quarter ended March 31, 2025 |
| Vanguard Group | 9,311,600 | 9.96% | Form 13F, quarter ended March 31, 2025 |
| Farallon Partners, L.L.C. | 7,826,338 | 8.37% | Schedule 13G, filed February 5, 2026 |
| BlackRock | 7,656,569 | 8.19% | Form 13F, quarter ended March 31, 2025 |
| Wellington Management | 6,891,397 | 7.37% | Form 13F, quarter ended March 31, 2025 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 6,395,922 | 6.84% | Schedule 13G, filed May 15, 2026 |
| T. Rowe Price | 5,112,360 | 5.47% | Form 13F, quarter ended March 31, 2025 |
| State Street | 3,283,275 | 3.51% | Form 13F, quarter ended March 31, 2025 |
| Franklin Templeton | 963,281 | 1.03% | Form 13F, quarter ended March 31, 2025 |
| Northern Trust | 857,081 | 0.92% | Form 13F, quarter ended March 31, 2025 |
Percentages above are of 93,525,000 shares outstanding, as reported by CRINETICS PHARMACEUTICALS INC. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At CRINETICS PHARMACEUTICALS INC.'s shareholder meeting held June 11, 2025, in the 2024-2025 proxy season, 245 asset managers reported votes on at least one of its 5 ballot items in their SEC Form N-PX filings, covering 1,761 separate fund positions. On the most widely held item on that ballot — To consider and vote upon, on an advisory basis, the compensation of the Company's named… — CRINETICS PHARMACEUTICALS INC.'s filing reports the proposal as approved, with 97% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: CRINETICS PHARMACEUTICALS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 12, 2025.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from CRINETICS PHARMACEUTICALS INC.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
CRINETICS PHARMACEUTICALS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Proxy Votes Now, “CRINETICS PHARMACEUTICALS INC. 2025 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/crinetics-pharmaceuticals-inc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.